Ultra‐High‐Throughput Viscoelastic Squeezing for Mechanoporation and Efficient Intercellular Delivery
Source abstract
Abstract
Abstract Cell‐based therapies have transformed the treatment landscape for a range of diseases, leveraging both genome modification and cell reprogramming to create targeted treatments. Such therapies rely on the efficient internalization of biomolecules into living cells. Unfortunately, existing cargo delivery methods, such as those based on viral vectors and electroporation, are often compromised by cytotoxicity, poor delivery efficiencies, and low throughput. To overcome these limitations, a viscoelastic squeezing methodology is presented that uses viscoelastic microfluidics to perform mechanoporation in a rapid and contact‐free manner. Through the control of the flow rates of a sample stream containing cells and cargo and a surrounding viscoelastic sheath flow, the width of a “virtual channel” formed between the two streams can be regulated. Elastic forces generated within this virtual channel are then used to deform contained cells and internalize user‐defined payloads. The effectiveness and utility of the platform are assessed through the delivery of mRNA, plasmid DNA, and clustered regularly interspaced short palindromic repeats (CRISPR‐Cas9) ribonucleoprotein complexes into a variety of cell lines. Data confirms that viscoelastic squeezing provides for enhanced delivery efficiencies when compared to conventional poration techniques, whilst maintaining high cell viabilities and throughputs of 20 million cells per minute, and thus represents a powerful tool for cellular engineering.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Microfluidic and Bio-sensing Technologies · Erythrocyte Function and Pathophysiology · Cellular Mechanics and Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute for Chemical and Bioengineering ETH Zürich Zürich 8093 Switzerland
Department of Neurology University Hospital Zürich Zürich 8091 Switzerland
Clinical Neuroscience Center University of Zürich Zürich 8091 Switzerland
References (81)
Show source-provided references
1. 10.1007/s11033-023-09096-810.1007/s11033-023-09096-8 ↗
2. 10.1038/nature1581810.1038/nature15818 ↗
3. 10.1038/s41565-019-0382-510.1038/s41565-019-0382-5 ↗
4. 10.1002/advs.20200459510.1002/advs.202004595 ↗
5. 10.1038/nrg106610.1038/nrg1066 ↗
6. 10.1093/hmg/ddv45110.1093/hmg/ddv451 ↗
7. 10.1002/adhm.20220268810.1002/adhm.202202688 ↗
8. 10.1038/nrd177510.1038/nrd1775 ↗
9. 10.1007/s10439-012-0678-110.1007/s10439-012-0678-1 ↗
10. 10.1021/acs.chemrev.7b0067810.1021/acs.chemrev.7b00678 ↗
11. 10.1038/nature1976410.1038/nature19764 ↗
12. 10.1158/0008-5472.CAN-10-288010.1158/0008-5472.CAN-10-2880 ↗
13. 10.3390/bios1405025610.3390/bios14050256 ↗
14. 10.1038/s41551-017-003910.1038/s41551-017-0039 ↗
15. 10.1002/advs.20190055710.1002/advs.201900557 ↗
16. 10.1016/j.matchemphys.2021.12460410.1016/j.matchemphys.2021.124604 ↗
17. 10.1021/acsbiomaterials.0c0078510.1021/acsbiomaterials.0c00785 ↗
18. 10.1016/j.mtbio.2021.10019310.1016/j.mtbio.2021.100193 ↗
19. 10.1186/s43094-020-00176-110.1186/s43094-020-00176-1 ↗
20. 10.1021/acs.nanolett.9b0317510.1021/acs.nanolett.9b03175 ↗
21. 10.1021/acsnano.0c1047310.1021/acsnano.0c10473 ↗
22. 10.1039/C9LC00041K10.1039/C9LC00041K ↗
23. 10.1038/s41598-019-40147-y10.1038/s41598-019-40147-y ↗
24. 10.1002/adfm.20190989010.1002/adfm.201909890 ↗
25. 10.1016/j.mattod.2018.03.00210.1016/j.mattod.2018.03.002 ↗
26. 10.1002/adtp.20190013010.1002/adtp.201900130 ↗
27. 10.1073/pnas.121870511010.1073/pnas.1218705110 ↗
28. 10.1126/sciadv.150045410.1126/sciadv.1500454 ↗
29. 10.1021/acsnano.0c0516910.1021/acsnano.0c05169 ↗
30. 10.1039/D0LC01224F10.1039/D0LC01224F ↗
31. 10.1021/acs.nanolett.8b0070410.1021/acs.nanolett.8b00704 ↗
32. 10.1038/s41598-021-91307-y10.1038/s41598-021-91307-y ↗
33. 10.1038/s41467-023-44447-w10.1038/s41467-023-44447-w ↗
34. 10.1126/sciadv.abj113310.1126/sciadv.abj1133 ↗
35. 10.1063/1.291171610.1063/1.2911716 ↗
36. 10.1016/0376-7388(94)87011-X10.1016/0376-7388(94)87011-X ↗
37. ATCC. EL4 (ATCC® TIB‐39 TM). ATCC https://www.atcc.org/products/tib‐39 (accessed: November 2024).
38. 10.1529/biophysj.105.06749610.1529/biophysj.105.067496 ↗
39. 10.1002/sca.2014410.1002/sca.20144 ↗
40. EL4 (ACC 831). DSMZ Cell Culture Catalogue https://webshop.dsmz.de/en/human‐animal‐cell‐lines/EL‐4.html (accessed November 2024).
41. LN229 (ATCC® CRL‐2611TM) ATCC.ATTC https://www.atcc.org/products/crl‐2611 (accessed: November 2024).
42. 10.1021/ac101964910.1021/ac1019649 ↗
43. 10.1016/j.colsurfb.2022.11278410.1016/j.colsurfb.2022.112784 ↗
44. 10.1021/acs.analchem.4c0117510.1021/acs.analchem.4c01175 ↗
45. 10.1039/D1BM01658J10.1039/D1BM01658J ↗
46. 10.1186/s12951-021-00801-y10.1186/s12951-021-00801-y ↗
47. 10.1016/j.jconrel.2010.10.02010.1016/j.jconrel.2010.10.020 ↗
48. 10.1038/s41598-021-00893-410.1038/s41598-021-00893-4 ↗
49. 10.1016/j.ijbiomac.2021.05.19210.1016/j.ijbiomac.2021.05.192 ↗
50. Odak A. · Blood · 2023 · 14 · 2698
51. 10.1186/s12967-022-03747-310.1186/s12967-022-03747-3 ↗
52. 10.7150/thno.4700710.7150/thno.47007 ↗
53. 10.1016/S0022-3565(24)29466-010.1016/S0022-3565(24)29466-0 ↗
54. 10.1016/j.neuropharm.2019.02.02210.1016/j.neuropharm.2019.02.022 ↗
55. 10.3389/fphar.2024.134147210.3389/fphar.2024.1341472 ↗
56. 10.1002/mds.2914710.1002/mds.29147 ↗
57. 10.3389/fnmol.2018.0027910.3389/fnmol.2018.00279 ↗
58. 10.1371/journal.pone.007590110.1371/journal.pone.0075901 ↗
59. Nepagene “Transfection into Cell Lines by Electroporation.” Nepagenehttps://nepagene.jp/en/applications/electroporation‐en/cell‐cultures‐e/cell‐lines‐2 (accessed: November 2024).
60. 10.1016/j.bbamem.2016.03.03210.1016/j.bbamem.2016.03.032 ↗
61. 10.1002/aic.1431810.1002/aic.14318 ↗
62. 10.1111/aor.1283210.1111/aor.12832 ↗
63. 10.1007/s10404-023-02701-z10.1007/s10404-023-02701-z ↗
64. 10.1039/D2LC01115H10.1039/D2LC01115H ↗
65. 10.1039/D2LC00692H10.1039/D2LC00692H ↗
66. 10.1021/acsnano.5c0100010.1021/acsnano.5c01000 ↗
67. 10.1016/j.snb.2025.13795310.1016/j.snb.2025.137953 ↗
68. 10.1007/s00253-024-13003-x10.1007/s00253-024-13003-x ↗
69. 10.1371/journal.pone.002092310.1371/journal.pone.0020923 ↗
70. 10.1038/mtm.2014.5810.1038/mtm.2014.58 ↗
71. 10.1038/s41467-018-06738-510.1038/s41467-018-06738-5 ↗
72. 10.1146/annurev-chembioeng-080615-03355910.1146/annurev-chembioeng-080615-033559 ↗
73. 10.1016/j.mtbio.2022.10051810.1016/j.mtbio.2022.100518 ↗
74. 10.1038/s41392-019-0089-y10.1038/s41392-019-0089-y ↗
75. 10.3389/fimmu.2024.135482510.3389/fimmu.2024.1354825 ↗
76. 10.1126/science.add966510.1126/science.add9665 ↗
77. 10.3389/fimmu.2021.70263610.3389/fimmu.2021.702636 ↗
78. 10.1039/c0sc00229a10.1039/c0sc00229a ↗
79. 10.1038/ncomms1246310.1038/ncomms12463 ↗
80. 10.1038/s41598-019-38809-y10.1038/s41598-019-38809-y ↗
81. Thermo Fisher Scientific. “Cell‐Line Specific CRISPR RNP Electroporation Conditions Using Neon System ” https://www.thermofisher.com/ch/en/home/life‐science/genome‐editing/genome‐editing‐learning‐center/genome‐editing‐resource‐library/crispr‐validated‐protocols/cell‐line‐specific‐crispr‐rnp‐electroporation‐conditions‐neon‐system.html(accessed: November 2024).